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FGF21 Mediates the Thermogenic and
Insulin-Sensitizing Effects of Dietary
Methionine Restriction but Not Its
Effects on Hepatic Lipid Metabolism

METABOLISM

Diabetes 2017;66:858–867 | DOI: 10.2337/db16-1212

Dietary methionine restriction (MR) produces an integrated
series of metabolic and physiological responses that persistently improve biomarkers of metabolic health (1–3). The
most prominent physiological responses are coordinated increases in energy intake and expenditure (2), with the larger
effect on energy expenditure (EE) limiting net increases in
fat deposition and accumulation of body weight (BW) (4).

The MR diet also increases in vivo insulin sensitivity
through a combination of direct and indirect effects on
the liver, adipose tissue, and muscle (5). Although progress has been made in identifying the molecular sensors
that detect MR (6–13), a full accounting of the speciﬁc
mechanisms linking reduced methionine to its metabolic
phenotype remains incomplete. The MR-induced improvement in insulin sensitivity is partly due to reductions in
adiposity, but the MR diet also increases tissue-speciﬁc insulin sensitivity through mechanisms that are independent
of differences in adiposity (4). For example, MR-dependent
reductions in hepatic glutathione signiﬁcantly enhance
insulin signaling by slowing glutathione-dependent degradation of PIP3 (5). Dietary MR also increases secretion of the
insulin sensitizer, adiponectin, from adipose tissue (2,3,14),
but the ability of MR to enhance insulin sensitivity appears
uncompromised in adiponectin-null mice (15).
Another promising mediator of the physiological
effects of dietary MR is FGF21. Within hours of initiating
dietary MR, hepatic transcription and release of FGF21
into the serum is increased by four- to ﬁvefold (5,13). The
evidence is compelling that FGF21 is a powerful metabolic
regulator in the context of glucose homeostasis, lipid metabolism, and energy balance (16–22), but controversy
remains about how FGF21 signaling is anatomically organized to produce its multiple physiological effects. To
date, the biological responses to FGF21 have been cataloged in studies where FGF21 was infused at high doses or
increased via transgenic overexpression, so whether the
physiological increases produced by MR are sufﬁcient to
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Dietary methionine restriction (MR) produces a rapid and
persistent remodeling of white adipose tissue (WAT), an
increase in energy expenditure (EE), and enhancement of
insulin sensitivity. Recent work established that hepatic
expression of FGF21 is robustly increased by MR. Fgf212/2
mice were used to test whether FGF21 is an essential
mediator of the physiological effects of dietary MR. The
MR-induced increase in energy intake and EE and activation of thermogenesis in WAT and brown adipose tissue
were lost in Fgf212/2 mice. However, dietary MR produced
a comparable reduction in body weight and adiposity in
both genotypes because of a negative effect of MR on
energy intake in Fgf212/2 mice. Despite the similar loss in
weight, dietary MR produced a more signiﬁcant increase
in in vivo insulin sensitivity in wild-type than in Fgf212/2
mice, particularly in heart and inguinal WAT. In contrast,
the ability of MR to regulate lipogenic and integrated stress
response genes in liver was not compromised in Fgf212/2
mice. Collectively, these ﬁndings illustrate that FGF21 is a
critical mediator of the effects of dietary MR on EE, remodeling of WAT, and increased insulin sensitivity but not of its
effects on hepatic gene expression.
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elicit all of the responses produced by pharmacological
modulation of FGF21 is unclear (23). However, many if
not most of the metabolic, transcriptional, and signaling
effects attributed to FGF21 are fully reproduced by dietary
MR (1,2,4,5,24). Using Fgf212/2 mice and dietary MR in
both low-fat and high-fat (HF) contexts, we report here
that FGF21 is an essential mediator of the effects of MR
on EE and energy intake but not overall energy balance due
to a paradoxical decrease in intake of the MR diet in
Fgf212/2 mice. The greater enhancement of insulin sensitivity by MR in wild-type (WT) versus Fgf212/2 mice, despite a comparable loss of BW, suggests a partial but
signiﬁcant FGF21-dependent role in the mechanism. In
contrast, the expected transcriptional responses to MR in
the liver are fully intact in Fgf212/2 mice, supporting a
FGF21-independent mechanism of action.
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as the ratio of VCO2 produced to VO2 consumed. EE was
calculated as (VO2*[3.815 + {1.232*RQ}]*4.1868).
Experiment 2

The vertebrate animal experiments in this study were
reviewed and approved by the Pennington Institutional
Animal Care and Use Committee using guidelines established by the National Research Council, the Animal Welfare
Act, and the Public Health Service Policy on humane care
and use of animals.

Five-week old male WT (n = 20) and Fgf212/2 (n = 20)
C57BL/6J mice were acclimated to the CON diet for
1 week, and then half the mice of each genotype were
switched to the MR diet while the other half continued
on the CON diet. Food intake, BW, and composition were
measured weekly for 9 weeks before all mice were adapted
to the TSE system for 2 days, followed by measurement of
VO2, VCO2, activity, and food intake at 40-min intervals
for 3 days. Mice were euthanized 1 week later, and tissues
were harvested after a 4-h fast. Group differences in EE
(kJ/mouse/h) were compared using ANCOVA (JMP Statistical Software, version 11; SAS Institute Inc., Cary, NC),
calculating least squares means that accounted for variation in EE attributable to differences in lean mass, fat
mass, activity, energy intake, genotype, diet, and genotype 3 diet interaction (4). The least squares means 6
SEM for the genotype 3 diet combinations were compared using a two-way ANOVA, and the signiﬁcance of
the model effects and interaction were tested using residual variance calculated by ANCOVA.

Animals and Diets

Experiment 3

RESEARCH DESIGN AND METHODS

Fgf212/2 mice on the C57BL/6J genetic background were
provided by Dr. Steven Kliewer (UT Southwestern). Two
different dietary formulations of the control (CON) and
MR diets, differing in energy density, were manufactured
by Dyets Inc. (Bethlehem, PA). The energy content of the
CON (Dyets #510072) and MR diets (Dyets #510071)
used in experiments 1–3 was 15.96 kJ/g, with 18.9% of
energy from fat (corn oil), 64.9% from carbohydrate, and
14.8% from a custom mixture of L-amino acids. The
amino acid content of the diets on a weight basis was
14.1%. The CON diet contained 0.86% methionine, and
the MR diet contained 0.17% methionine. For experiment
4, the energy density of the CON and MR diets was
increased to 22.8 kJ/g, with 59.6% of energy from fat
(lard and soybean oil), 25.7% from carbohydrate, and
14.7% from L-amino acids. The HF CON diet contained
0.86% methionine, and the HF MR diet contained
0.17% methionine. Food and water were provided ad
libitum, and lights were on 12 h/day from 7 A.M. to 7 P.M.
Mice were euthanized by CO 2 narcosis, followed by
decapitation.
Experiment 1

Five-week-old male WT (n = 16) and Fgf212/2 (n = 16)
C57BL/6J mice were acclimated to the CON diet for
1 week before the mice were adapted to the TSE Indirect
Calorimetry system. All mice received the CON diet during
the adaptation period. Thereafter, eight mice of each genotype were switched to the MR diet and eight mice of each
genotype continued on the CON diet. VO2 and VCO2
were measured at 40-min intervals for an additional
11–12 days. The respiratory quotient (RQ) was calculated

A third cohort of WT (n = 20) and Fgf212/2 (n = 20) mice
was shipped to the Vanderbilt Phenotyping Center at 5 weeks
of age to undergo hyperinsulinemic-euglycemic clamps as
previously described (5,25). Mice of each genotype were
fed the CON diet for 3 weeks before being randomized to
the CON or MR diet for the following 13 weeks before
surgery for catheter placement. After a 5-day recovery,
clamps were performed in conscious mice after a 5-h fast.
Insulin (2.5 mU/kg/min) was infused with a 50% dextrose
solution at a variable rate to maintain euglycemia. Wholebody glucose turnover was assessed with a 5 mCi bolus of
[3-3H]glucose tracer 1.5 h before insulin treatment, followed
by a 0.05 mCi/min infusion during the clamp. Insulinstimulated glucose uptake in individual organs was
determined using 2-[14C]deoxyglucose ([14C]2-DG) administered as a single bolus (13 mCi) 120 min after the start of
clamp procedure. At t = 145 min, epididymal WAT, inguinal
WAT (IWAT), brown adipose tissue (BAT), gastrocnemius
muscle, vastus lateralis muscle, soleus muscle, brain, and
heart were harvested for analysis. Steady-state glucose infusion rates (GIRs), glucose levels, plasma insulin, BWs,
and Rg in each tissue were compared by two-way ANOVA.
Experiment 4

Male WT (n = 24) and Fgf212/2 (n = 24) C57BL/6J mice
(12 weeks old) were acclimated to the HF CON diet for
4 weeks before half of the mice of each genotype were
switched to the HF MR diet. Food intake, BW, and composition were measured weekly for 8 weeks. After a 2-week
recovery, mice were adapted to TSE system for 2 days, followed by measurement of VO2, VCO2, activity, and food
intake at 40-min intervals for 3 days. Data were analyzed
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as described for experiment 2. Tissues and serum were
harvested 1 week after indirect calorimetry after a 4-h fast.

CA) by measurement of SYBR Green. mRNA concentrations
were normalized to cyclophilin expression.

Western Blotting

Histology

Expression of fatty acid synthase (FASN), and stearyl-CoA
desaturase (SCD-1) were measured by Western blotting as
previously described (1). The FASN antibody was from
Santa Cruz (Dallas, TX), the b-actin antibody was from
Sigma-Aldrich (St. Louis, MO), and the afﬁnity-puriﬁed
SCD-1 antibody was described previously (1). Detected
proteins were quantitated using ImageJ software, and the
relative expression of the target protein versus b-actin was
calculated to test for genotype and diet effects.

Parafﬁn-embedded IWAT tissues from experiment 1 were
sectioned at 5 mm and stained for hematoxylin and eosin
as previously described (26).
Liver and Serum Triglyceride

Serum and lipid triglyceride levels were measured as previously described (2).
RESULTS

RNA Isolation and Quantitative Real-Time PCR

Role of FGF21 in MR-Induced Effects on EE
and Energy Balance

Total RNA was isolated using an RNeasy Mini Kit (QIAGEN
Inc., Valencia, CA). One microgram of total RNA was reverse
transcribed to produce cDNA. Gene expression was measured by real-time PCR (Applied Biosystems, Foster City,

Comparison of the acute effects of dietary MR on EE in
WT and Fgf212/2 mice showed that the diet signiﬁcantly
increased EE at day 6 in WT mice and expanded the magnitude of the effect over the subsequent 6 days (Fig. 1A). In

Figure 1—Assessment of acute and chronic effects of dietary MR on EE and energy balance in WT and Fgf212/2 mice. EE was measured by
indirect calorimetry in WT (A) and Fgf212/2 mice (B). Mice fed the CON diet were placed in the TSE calorimeters and were randomized to
remain on CON or switched to MR while in the TSE. The effect of diet on 24-h EE was compared for each day within genotype during the
following 11 days. Days annotated with an * differ from mice fed the CON diet at P < 0.05. Change in BW (C), fat mass (D), energy intake per
mouse (E), and energy intake per unit BW (F) for 9 weeks in WT and Fgf212/2 mice after initiation of dietary MR. Means 6 SEM are presented
for weekly measurements in 8 mice per diet per genotype, and means annotated with * and # differ from mice of the same genotype fed the
CON diet at P < 0.05. Least squares means 6 SEM of EE (G) and RQ (H) determined after 9 weeks on respective diets and measured over
3 days in eight mice per diet per genotype. Least squares means of EE were calculated by ANCOVA as described in RESEARCH DESIGN AND
METHODS. EE and RQ were compared by a two-way ANOVA. Means annotated with a different letter (a, b, c) differ at P < 0.05. I: Hematoxylin
and eosin stains of representative sections of IWAT from WT and Fgf212/2 mice fed the CON or MR diet for 9 weeks.

diabetes.diabetesjournals.org

contrast, dietary MR had no effect on EE in Fgf212/2 mice
in the ﬁrst 11 days the diet was provided (Fig. 1B), supporting the view that FGF21 is required for the acute increase in EE produced by MR.
BW of WT and Fgf212/2 mice fed the CON diet did not
differ at the beginning of experiment 2, but BW diverged
slightly over the ﬁnal 5 weeks, with WT mice ending the
study slightly but not signiﬁcantly heavier than Fgf212/2
mice (Fig. 1C). In WT and Fgf212/2 mice fed the CON diet,
the change in fat mass over time paralleled the change in
BW (Fig. 1D). This difference in BW in mice fed the CON
diet is reﬂected in the slightly but not signiﬁcantly higher
energy intake in WT mice compared with Fgf212/2 mice
(Fig. 1E). Dietary MR produced a signiﬁcant increase in
energy intake in WT mice during the entire study (Fig.
1E), but their accumulation of BW and fat mass was signiﬁcantly lower than WT mice fed the CON diet (Fig.
1C and D). In contrast, MR decreased energy intake
in Fgf212/2 mice after 4 weeks, and the decrease translated into reduced accumulation of BW and fat mass in
Fgf212/2 mice fed the MR diet (Fig. 1C and D). However,
the identical energy intake per unit BW of Fgf212/2 mice
fed the respective diets indicates that the loss in BW and fat
mass of Fgf212/2 mice fed the MR diet is accounted for by
their reduction in intake per mouse (Fig. 1E and F). The
primary effect of MR on body composition in both genotypes was to reduce fat deposition (Fig. 1D), but the mechanism in WT mice was an increase in EE (Fig. 1A and G),
whereas the mechanism in Fgf212/2 mice was reduced energy intake (Fig. 1E). The indirect calorimetry conducted at
the end of the study showed that MR signiﬁcantly increased
EE in WT mice but was without effect in Fgf212/2 mice (Fig.
1G). Dietary MR failed to reduce RQ in either genotype, and
the RQs were similar across genotypes within the diet (Fig.
1H). The appearance of WAT was also differentially affected
by MR between the genotypes, with MR producing the previously shown remodeling of cell and fat droplet morphology
in the inguinal depot (4,27) of WT mice and only a modest
reduction in adipocyte size in Fgf212/2 mice (Fig. 1I). Together, these ﬁndings illustrate that FGF21 is an essential
mediator of the effects of dietary MR on energy intake, EE,
and remodeling of WAT.
Role of FGF21 in MR-Induced Effects on Insulin
Sensitivity

We previously showed that dietary MR for 8–10 weeks
produces a two- to threefold increase in overall insulin
sensitivity (5,13). To test whether FGF21 was an essential
mediator of this effect, hyperinsulinemic-euglycemic
clamps were used to assess insulin sensitivity in WT
and Fgf212/2 mice. The GIRs needed to establish euglycemia after the insulin infusion was initiated were comparable between WT and Fgf212/2 mice fed the CON diet,
and MR produced a signiﬁcant increase in steady-state
GIR between 80 to 120 min in both genotypes (Fig. 2A).
The steady-state levels of blood glucose during the clamp
were comparable among the groups (Fig. 2B), as were
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plasma insulin levels before and during the clamp (Fig.
2C). The MR-dependent increase in GIR in WT mice was
nearly threefold, whereas the increase in Fgf212/2 mice
was approximately twofold (Fig. 2A). MR produced a comparable reduction in BW in this study (Fig. 2D) and a
slightly greater reduction in fat mass in experiment
2 (Fig. 1D). Thus, the slightly greater improvement in overall insulin sensitivity produced by MR in WT compared
with Fgf212/2 mice suggests a body size– or compositionindependent component of the improvement in insulin
sensitivity that is FGF21 dependent (Fig. 2A). The Rg provides a measure of insulin-dependent plus -independent
glucose uptake and showed that MR enhanced [14C]2-DG
uptake by two- to threefold in gastrocnemius muscle,
vastus lateralis muscle, soleus muscle, and heart in WT
mice (Fig. 2E and F). In contrast, the MR-dependent increase in skeletal muscle Rg in Fgf212/2 mice was intermediate in that it did not differ from Fgf212/2 mice fed the
CON diet or WT mice fed the MR diet (Fig. 2E). In the
heart, MR had no detectable effect on Rg in Fgf212/2 mice
(Fig. 2F). MR did increase Rg by fourfold in IWAT of
Fgf212/2 mice, whereas the increase in WT mice was ninefold, indicating a more signiﬁcant effect of MR when
FGF21 was present (Fig. 2G). Together, these data provide
compelling evidence that FGF21 is an essential mediator of
the insulin-sensitizing effects of MR, working through both
weight-dependent and -independent mechanisms.
Role of FGF21 in Reversal of Diet-Induced Obesity
by Dietary MR

After WT and Fgf212/2 mice were adapted to the HF
CON diet for 4 weeks, initiation of the HF MR diet produced an immediate and comparable reversal of BW (Fig.
3A) and fat accumulation (Fig. 3B) in both genotypes.
During this ﬁrst 4-week period, BW and fat mass decreased in parallel in each genotype and remained essentially constant during the last 4 weeks of the study (Fig.
3A and B). By comparison, the BW and fat mass of WT
and Fgf212/2 mice fed the HF CON diet steadily increased during the 8-week study (Fig. 3A and B). The
40% reduction in BW of WT mice fed the HF MR diet
versus the HF CON diet occurred despite a 30% higher
rate of energy intake in WT mice fed the HF MR diet
compared with the HF CON diet (Fig. 3C). Even after
energy intake was adjusted to the difference in BW, WT
mice fed the HF MR diet were still consuming signiﬁcantly more than WT mice fed the HF CON diet (Fig.
3D), indicative of a higher rate of EE. In contrast, the
rapid and signiﬁcant loss of BW in Fgf212/2 mice fed
the HF MR diet is entirely attributable to a reduction in
energy intake that becomes evident after 2 weeks and
persists for 4 of the 8 weeks of the study (Fig. 3C). Measurements of EE after 9 weeks on the respective diets
support this conclusion and show that MR produced a
signiﬁcant increase in EE in WT but not Fgf212/2 mice
(Fig. 3E). The HF conﬁgurations of the CON and MR diets
reduced RQs to ;0.8 in all groups, and no genotype, diet,
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Figure 2—Hyperinsulinemic-euglycemic clamps in WT and Fgf212/2 mice after 13 weeks of dietary MR to test for effects on overall insulin
sensitivity and insulin-dependent 2-DG uptake among tissues. The clamp procedures were conducted as described in RESEARCH DESIGN AND METHODS.
A: The GIR required to maintain euglycemia during the insulin clamps is shown. Blood glucose concentration (B) and plasma insulin concentration (C)
are shown before and during the insulin clamps. D: The effect of the CON and MR diets on the respective BWs of WT and Fgf212/2 mice is shown.
Rg is shown for skeletal muscle (E); BAT, heart, and brain (F); and epididymal WAT (EWAT) and IWAT (G). Rg provides a measure of insulin-dependent
plus insulin-independent glucose uptake in each tissue. The Rg for each tissue were compared by two-way ANOVA and means 6 SEM are based on
n = 7–9 mice per genotype and diet. Means annotated with different letters (a, b, c) within each tissue differ at P < 0.05.

or genotype 3 diet interactions were detected (Fig. 3F). Thus,
in both low-fat and HF contexts, FGF21 appears to be an
essential mediator of MR’s effect on energy intake and EE.
Role of FGF21 as a Mediator of Transcriptional
Effects of Dietary MR in the Liver

To examine the role of FGF21 as a mediator of the transcriptional effects of MR in the liver, previously identiﬁed
targets of MR were measured in mice from experiment 4.
For example, previous studies identiﬁed lipogenic genes as
targets and showed that MR produced a coordinated
downregulation of these genes (1). Examination of the
key genes involved in hepatic de novo lipogenesis (e.g.,
Scd1, Fasn, Acc1) in WT and Fgf212/2 mice showed that
the HF MR diet reduced Scd1 mRNA expression by ;10fold and Fasn mRNA by ;2-fold in WT and Fgf212/2
mice (Fig. 4A). The reduction in hepatic Acc1 mRNA by
MR was not signiﬁcant in either genotype. Dietary MR
also produced comparable reductions in SCD-1 (Fig. 4B)
and FASN (Fig. 4C) protein expression in both genotypes.

Hepatic triglyceride levels were reduced by twofold by MR
in WT mice and were accompanied by a signiﬁcant decrease
in serum triglycerides (Fig. 4D). MR produced a larger
threefold reduction in hepatic triglycerides in Fgf212/2
mice but had no effect on serum triglycerides. We recently
showed that MR regulated the integrated stress response in
liver by activation of NRF2 and ATF4 (13). Figure 4E shows
that the transcriptional activation of genes from these pathways was comparable between WT and Fgf212/2 mice. Together, these ﬁndings support the view that FGF21 is not
required for MR-dependent regulation of lipogenic, NRF2dependent, or ATF4-dependent genes in the liver.
Role of FGF21 as a Mediator of Transcriptional
Effects of Dietary MR in Adipose Tissue

Consumption of a MR diet induces signiﬁcant browning
of WAT and activation of thermogenesis in BAT (2,4,14,27).
The MR diet also remodels WAT lipid metabolism by upregulating lipogenic gene expression (1). To explore the role of
FGF21 in MR-dependent transcriptional responses in BAT

diabetes.diabetesjournals.org
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Figure 3—Assessment of chronic effects of HF CON and HF dietary MR on energy balance and EE in WT and Fgf212/2 mice. WT and
Fgf212/2 mice (12 weeks old) were fed the HF CON diet for 4 weeks before half of the mice of each genotype were randomized to remain
on the HF CON diet and the remaining half of mice were switched to the HF MR diet. Change in BW (A), fat mass (B), energy intake per
mouse (C), and energy intake per unit BW (D) for 8 weeks in WT and Fgf212/2 mice after initiation of dietary MR. Means 6 SEM are
presented for weekly measurements in 10 mice per diet per genotype. Means annotated with symbols (*, #) differ from mice of the same
genotype fed the CON diet at P < 0.05. Least squares means 6 SEM of EE (E) and RQ (F) determined after 8 weeks on respective diets and
measured over 3 days in eight mice per diet per genotype (E). Means annotated with a different letter (a, b, and c) differ at P < 0.05.

and WAT, we measured transcriptional markers of thermogenesis in BAT and lipogenesis and browning in IWAT from
each genotype of experiment 4. In WT mice, the HF MR diet
produced signiﬁcant increases in markers of thermogenesis
(Ucp1, Bmp8b, Cidea, Elov3) in BAT (Fig. 5A), lipogenesis
(Scd1, Fasn, Acc1, Elovl6) in IWAT (Fig. 5B), and thermogenic
remodeling (Ucp1, Cox7a1, Cox8b, Cidea) in IWAT (Fig. 5C). In
contrast, with the exception of a positive effect on Acc1 in
IWAT, the MR diet was ineffective in inducing the thermogenic or lipogenic programs in BAT and WAT of Fgf212/2
mice (Fig. 5A–C). Together these ﬁndings illustrate that
FGF21 is an essential mediator of the transcriptional programs induced by dietary MR in BAT and WAT.
DISCUSSION

Dietary MR produces a coordinated series of biochemical and physiological responses that develop soon after
initiation of MR and persist for as long as the diet is

consumed (3,14,28–31). The biological signiﬁcance of
these effects in aggregate is substantial, resulting in animals that are leaner, more insulin sensitive, and live
longer (1,2,24,32,33). The most signiﬁcant unanswered
questions pertain to how the reduction in dietary methionine is sensed and how these sensing mechanisms are
coupled to tissue-speciﬁc responses that produce the
resulting metabolic phenotype. Previous studies establish
that dietary MR produces a rapid, robust, and persistent
increase in hepatic transcription and release of FGF21
(4,5,15,34). The evidence is also compelling that FGF21
is a powerful metabolic regulator in the context of glucose homeostasis, lipid metabolism, and energy balance
(16–22), but controversy remains about how FGF21 signaling is anatomically organized to produce its multiple physiological effects. The biological responses to FGF21 have
been documented in studies where FGF21 was infused at
high doses or increased via transgenic overexpression, so it
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Figure 4—Effects of HF CON and HF dietary MR on hepatic gene expression and on liver and serum triglycerides in WT and Fgf212/2 mice.
WT and Fgf212/2 mice (12 weeks old) were fed the HF CON diet for 4 weeks before half the mice of each genotype were randomized to
remain on the HF CON diet and the remaining half of mice were switched to the HF MR diet for 8 weeks. Effects of MR on hepatic lipogenic
gene expression (A and B) or NRF2-sensitive and ATF4-sensitive gene expression (E) were expressed as fold change in the MR group/CON
group within genotype for each gene (A and E). The respective mRNAs were measured by real-time PCR. Expression of SCD-1 (B) and
FASN (C) was determined in representative liver microsomes for SCD-1 and cytosol for FASN in mice from each genotype and diet.
Expression of SCD-1 and FASN were expressed relative to b-actin. D: Serum and liver triglycerides were measured as described in
RESEARCH DESIGN AND METHODS. Means in panel D that are annotated with different letters (a, b, c) within tissue differ at P < 0.05 (n = 10/group).
Fold-changes in expression for each gene in panels A and E are representative of 10 mice per diet per genotype. Means annotated with
an * differ from the CON diet within genotype at P < 0.05.

is unclear whether the physiological increases produced by
MR (e.g., 1 ng/mL to 8 ng/mL [13]) are sufﬁcient to elicit
all of the responses produced by pharmacological modulation of FGF21 (23). Many of the metabolic, transcriptional, and signaling effects attributed to FGF21 are fully
reproduced by dietary MR (1,2,4,5,24). For example,
FGF21 directly affects adiponectin secretion from adipocytes (35), increases lipogenic gene expression in WAT
(16), promotes browning of WAT (36), and increases thermogenic gene expression in BAT and WAT (36). Dietary
MR produces signiﬁcant browning of WAT (1,2,27), and
given the increased glucose uptake and utilization associated with browning (37), the suggestion that MR is functioning through this mechanism to increase insulin
sensitivity in WAT is attractive. However, recent reports
argue that the glycemic improvements produced by
FGF21 are independent of browning in WAT (38, 39)
and are dependent on direct effects of FGF21 in adipose
tissue (5,18,40,41). This view is also supported by studies
showing that pegylated FGF21, which is too large to penetrate the central nervous system (CNS), is fully effective
in normalizing glucose utilization in insulin-resistant states
(42). However, from the ﬁndings presented here, it seems
clear that MR-dependent increases in FGF21 affect tissue-

speciﬁc and overall insulin sensitivity through a combination of mechanisms involving both decreased adiposity and
direct effects of FGF21 in speciﬁc tissues.
Our previous work focused on liver and adipose tissue
not only as primary transcriptional targets of dietary MR
(1,24) but also as key sites for the insulin-sensitizing
effects of the diet (5,13). The current study provides intriguing new observations supporting the view that 1) the
heart is an important target for the enhancement of insulin-dependent glucose uptake by dietary MR and that 2)
FGF21 is required for the MR-dependent enhancement of
cardiac glucose uptake (Fig. 2F). Given the contribution of
the heart to whole-body glucose disposal in the mouse, it
seems likely that the MR-dependent increase in FGF21
plays a key role in enhancing overall insulin-dependent
glucose utilization through its effects on cardiac glucose
uptake. Pharmacological administration of FGF21 was also
shown to increase glucose uptake in the heart (22), but the
present observations are the ﬁrst to our knowledge of
physiologically relevant alterations of FGF21 enhancing
insulin-dependent glucose uptake in the heart. Mice lacking
the intestinal and renal neutral amino acid transporter
(e.g., Slc6a19) that transports dietary methionine into
the enterocyte have impaired absorption of dietary
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Figure 5—Effects of HF CON and HF dietary MR on gene expression
in BAT and WAT from WT and Fgf212/2 mice. WT and Fgf212/2 mice
(12 weeks old) were fed the HF CON diet for 4 weeks before half of
the mice of each genotype were randomized to remain on the HF
CON diet and the remaining half of mice were switched to the HF MR
diet for 8 weeks. Effects of MR on thermogenic gene expression in
BAT (A), lipogenic gene expression in IWAT (B), and browning genes
in IWAT (C) were expressed as fold change in the MR group/CON
group within genotype for mRNA levels for each gene and tissue. The
respective mRNAs were measured by real-time PCR, and the means
are representative of 10 mice per diet per genotype. Means annotated with an * differ from the CON diet within genotype at P < 0.05.

methionine and increased methionine excretion (43). Interestingly, Slc6a192/2 mice have elevated circulating FGF21
concentrations and enhanced glucose uptake, especially in
the heart (44). In contrast, liver-speciﬁc deletion of FGF21
does not seem to affect glucose uptake by the heart (45).
Considered together, the present ﬁndings make a compelling
case that the heart is an important metabolic target of
dietary MR by virtue of MR’s enhancement of hepatic
transcription and release of FGF21. In addition to direct
effects in peripheral tissues, FGF21 also acts centrally.
Although all of the CNS sites where FGF21 is acting remain ill deﬁned, FGF21 affects EE through an increase
in sympathetic nervous system outﬂow to adipose tissue
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(21,35,46,47). Dietary MR increases core temperature, EE,
and thermogenic function in BAT and WAT through increases in sympathetic nervous system stimulation of
adipose tissue (2,14). Our present ﬁndings make a compelling case that the MR-dependent increase in hepatic
FGF21 is the key event linking MR to its metabolic
effects on EE through remodeling of adipose tissue
and enhanced thermogenic capacity. Sorting out the relative contributions of peripheral versus central FGF21 signaling during MR will require careful phenotyping of loss of
MR-dependent effects after selective deletion of FGF21
signaling in the respective sites.
Comparisons of energy balance of WT and Fgf212/2
mice fed CON diets are also important in interpreting the
present ﬁndings. In mice fed the low-fat CON diet, BWs of
Fgf212/2 mice trended lower by the end of the study, and
this was likely the product of slightly lower energy intakes
and EE in Fgf212/2 compared with WT mice (Fig. 1C, E,
and G). This ﬁnding differs slightly from our earlier ﬁnding
of similar EE in WT and Fgf212/2 mice (13) but agrees with
previous reports of lower EE in Fgf212/2 compared with
WT mice (48, 49). In contrast, BWs were lower in Fgf212/2
than WT mice after 12 weeks on the HF CON diet (Fig. 3A),
and this occurred despite similar intake of the HF CON diet
during the study (Fig. 3C). Interestingly, EE in Fgf212/2
mice fed the HF CON diet was 6.4% higher than WT mice
(Fig. 3E), suggesting that the higher EE at equivalent energy
intake may have translated into reductions of BWs in
Fgf212/2 mice. Previous reports have detected no differences in BWs between WT and Fgf212/2 mice fed HF diets
(50,51), although the mice in those studies were somewhat
older than the mice used in this study.
The most surprising ﬁnding from the present work is
that Fgf212/2 mice fed the MR diet lost as much BW and
adiposity as WT mice. However, careful examination of the
data (Figs. 1 and 3) illustrates that MR affected weight and
adiposity in WT and Fgf212/2 mice through completely
different mechanisms. For example, despite increasing energy intake and EE in WT mice, the MR diet limited adipose
tissue accretion because of its proportionately larger effect
on EE. In contrast, the MR diet had no effect on EE in
Fgf212/2 mice and actually reduced their energy intake to
levels below that of Fgf212/2 mice fed the CON diet (Figs.
1E and 3C). This translated into comparable negative energy
balances between WT and Fgf212/2 mice fed the MR diet.
A further illustration that the weight loss of Fgf212/2 mice
fed the MR diet is exactly proportional to their decrease in
intake is obtained by expressing energy intake per unit BW.
Figures 1E and 3D show that the decreased weight gain in
Fgf212/2 mice fed the MR diet, relative to Fgf212/2 mice
fed the CON diet, is exactly proportional to their decrease in
intake. This interpretation assumes that MR is not altering
EE in Fgf212/2 mice fed the MR diet, which was conﬁrmed
by independent measurements of EE in these mice.
The mechanism underlying the negative effect of MR
on energy intake in Fgf212/2 mice is unknown. Low-protein
(LP) diets recapitulate the effects of MR on hepatic release
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of FGF21, increased energy intake, and increased EE in WT
mice, but recent work showed that the LP diet did not produce hypophagia in Fgf212/2 mice (52). Because of this
neutral effect on food intake, Fgf212/2 mice fed the LP
diet grew at the same rate as WT mice fed the CON diet
(52). A negative effect of MR on energy intake was also
observed in Ucp12/2 mice, where the MR diet also failed
to increase EE (4). Thus, a common feature of MR’s inability
to increase EE in Fgf212/2 and Ucp12/2 mice was the negative effect of the MR diet on energy intake. One interpretation of these data is that the MR-dependent increase in
energy intake is dependent on a coordinated MR-dependent
increase in EE. Arguing against such a mechanism are the
effects of dietary leucine deprivation, which results in food
aversion despite a signiﬁcant increase in EE (53–55). Perhaps the absence of FGF21 heightens the central perception
of reduced methionine such that it is interpreted as methionine deprivation with respect to energy intake. Cell type–
speciﬁc deletion of FGF21 signaling in CNS sites involved in
essential amino acid sensing would be one approach to test
this possibility.
The previously reported activation of NRF2-sensitive and
ATF4-sensitive genes by MR and the downregulation of
hepatic lipogenic genes and tissue triglycerides by MR (1,15)
were not compromised in Fgf212/2 mice, establishing that
FGF21 is not the mediator of these effects of MR in the
liver. We previously showed that addition of small amounts
of cysteine to the MR diet fully reversed the transcriptional
activation of hepatic Fgf21 by MR (13) but that the downregulation of Scd1 was unaffected. However, the activation
of NRF2- and ATF4-sensitive genes by MR in the liver was
reversed by adding cysteine back to the diet (13), supporting
our view that these transcriptional effects of MR are directly
linked to methionine/cysteine sensing in the liver and are
not secondary to FGF21. However, MR was unable to reduce
serum triglyceride in Fgf212/2 mice, suggesting a requirement for FGF21 for this effect. We believe this effect is
associated with FGF21-dependent remodeling of BAT and
WAT and the enhanced clearance of serum triglycerides by
enhanced thermogenesis (56). Recent work showed that
FGF21 lowered plasma triglycerides by accelerating lipoprotein catabolism in WAT and BAT (57). Thus, the failure of
MR to decrease serum triglycerides in Fgf212/2 mice was
due to the inability of MR to enhance thermogenic activity in BAT and WAT in the absence of FGF21. It will be
important to test this hypothesis experimentally using
tracer-based methods to measure fatty acid uptake and
utilization among tissues. On the basis of the present
ﬁndings, we propose that FGF21 is a key mediator linking
sensing of the reduction of dietary methionine in the liver
to its effects on energy balance, insulin sensitivity, and
adipose tissue remodeling, but not its transcriptional effects in the liver.
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